Ge Healthcare Technologies Inc.
GE HealthCare Announces Pricing for Upsized Secondary Offering
Summary
GE HealthCare Technologies Inc. announced the pricing for an upsized secondary underwritten public offering of 14,000,000 shares of its common stock. The offering was increased from the initially announced 13,000,000 shares. Notably, GE HealthCare itself is not selling any shares and will not receive any proceeds from the sale. Instead, General Electric Company is expected to exchange the shares for its debt held by Morgan Stanley Bank, N.A., before Morgan Stanley & Co. LLC, the selling stockholder, sells the shares to the underwriter. The offering is expected to close on March 15, 2024, subject to customary closing conditions.
Profitelligence Alerts
Get alerts for GEHC
Be first to know when Ge Healthcare Technologies Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Official SEC Documents
Advertisement